Estimating the number of relapsed and refractory indolent lymphoma patients across Europe, who are expected to initiate a new line of therapy (LOT)

Authors:

Ellis H, Neves C, Chapman A and Jeyakumaran D.

Publication type:

Poster PCN41

Conference name:

20th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress

Citation:

Ellis H, Neves C, Chapman A and Jeyakumaran D. Estimating the number of relapsed and refractory indolent lymphoma patients across Europe, who are expected to initiate a new line of therapy (LOT). 20th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Glasgow, Scotland. 4-8 November. Poster PCN41.

Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies